Viewing Study NCT02921256


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-02-24 @ 10:06 AM
Study NCT ID: NCT02921256
Status: COMPLETED
Last Update Posted: 2025-12-04
First Post: 2016-09-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rectal Adenocarcinoma View
None Stage II Rectal Cancer AJCC v7 View
None Stage III Rectal Cancer AJCC v7 View
Keywords: